Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001228684-26-000006

Director sold 12,500 shares at an average $62.12 ($776,495)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

LINK WILLIAM J PHD · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Sale : show line 1 in the form 10b5-1 −10,572 $61.97 $655,147 108,714 D
2026-06-15 Sale : show line 2 in the form 10b5-1 −1,928 $62.94 $121,348 106,786 D
Open-market sales · 12,500 sh · avg $62.12 · $776,495
Loading xslF345X06/wk-form4_1781727420.xml…